Still calculating financial ratios manually?
Stop wasting time — let the computer do it!
Achieve Life Sciences Inc. (ACHV) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
22722 29TH DR. SE SEATTLE, WA 98021 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
| 3/31/2026 MRQ | 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments, including: | 36,400,000 | 34,400,000 | 15,546,000 | 24,771,000 | 43,022,000 | 35,853,000 | |||
| Cash and cash equivalent | 20,929,000 | 12,753,000 | 15,546,000 | 24,771,000 | 43,022,000 | 35,853,000 | |||
| Short-term investments | 15,475,000 | 21,607,000 | |||||||
| Other undisclosed cash, cash equivalents, and short-term investments | (4,000) | 40,000 | |||||||
| Receivables | 111,000 | 105,000 | 153,000 | ||||||
| Other undisclosed current assets | 3,489,000 | 2,067,000 | 1,325,000 | 2,454,000 | 1,419,000 | 1,122,000 | |||
| Total current assets: | 39,889,000 | 36,467,000 | 16,982,000 | 27,330,000 | 44,594,000 | 36,975,000 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 64,000 | 119,000 | 66,000 | 123,000 | 64,000 | 146,000 | |||
| Property, plant, and equipment, after accumulated depreciation, depletion, and amortization | 3,000 | 8,000 | 13,000 | 4,000 | 15,000 | 42,000 | |||
| Intangible asset, including goodwill, after accumulated amortization | 1,785,000 | 2,008,000 | 2,231,000 | 2,452,000 | 2,675,000 | 2,898,000 | |||
| Goodwill | 1,034,000 | 1,034,000 | 1,034,000 | 1,034,000 | 1,034,000 | 1,034,000 | |||
| Intangible asset, excluding goodwill, after accumulated amortization | 751,000 | 974,000 | 1,197,000 | 1,418,000 | 1,641,000 | 1,864,000 | |||
| Restricted cash and investments | 50,000 | ||||||||
| Other noncurrent assets | 187,000 | ||||||||
| Other undisclosed noncurrent assets | 49,000 | 31,000 | 79,000 | 62,000 | 168,000 | ||||
| Total noncurrent assets: | 1,901,000 | 2,166,000 | 2,389,000 | 2,641,000 | 2,922,000 | 3,323,000 | |||
| TOTAL ASSETS: | 41,790,000 | 38,633,000 | 19,371,000 | 29,971,000 | 47,516,000 | 40,298,000 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 1,921,000 | 5,550,000 | 3,280,000 | 3,741,000 | 3,129,000 | 2,390,000 | |||
| Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | ✕ | 1,940,000 | 1,474,000 | ||
| Accounts payable | 1,950,000 | 618,000 | 1,660,000 | 841,000 | 332,000 | ||||
| Accrued liabilities | 1,921,000 | 3,600,000 | 2,662,000 | 2,081,000 | 348,000 | 584,000 | |||
| Debt | 3,704,000 | 16,662,000 | 16,071,000 | ||||||
| Business combination, contingent consideration, liability | 1,557,000 | ||||||||
| Other undisclosed current liabilities | 1,900,000 | 1,132,000 | 871,000 | 1,787,000 | 1,421,000 | 545,000 | |||
| Total current liabilities: | 9,082,000 | 6,682,000 | 20,813,000 | 21,599,000 | 4,550,000 | 2,935,000 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 11,185,000 | 9,837,000 | 14,924,000 | 77,000 | |||||
| Long-term debt, excluding current maturities | 11,185,000 | 9,837,000 | 14,920,000 | ||||||
| Liabilities, other than long-term debt | 5,000 | 1,215,000 | 6,000 | 69,000 | |||||
| Operating lease, liability | 5,000 | 66,000 | 6,000 | 69,000 | 4,000 | 77,000 | |||
| Business combination, contingent consideration, liability | 1,149,000 | ||||||||
| Other undisclosed noncurrent liabilities | (4,000) | (77,000) | |||||||
| Total noncurrent liabilities: | 11,190,000 | 11,052,000 | 6,000 | 69,000 | 14,924,000 | 77,000 | |||
| Total liabilities: | 20,272,000 | 17,734,000 | 20,819,000 | 21,668,000 | 19,474,000 | 3,012,000 | |||
| Equity | |||||||||
| Equity, attributable to parent | 21,518,000 | 20,899,000 | (1,448,000) | 8,303,000 | 28,042,000 | 37,286,000 | |||
| Common stock | 121,000 | 103,000 | 90,000 | 87,000 | 79,000 | 76,000 | |||
| Additional paid in capital | 281,613,000 | 226,343,000 | 164,209,000 | 144,148,000 | 121,545,000 | 97,640,000 | |||
| Accumulated other comprehensive income | 10,000 | 31,000 | 4,000 | 4,000 | 4,000 | 4,000 | |||
| Accumulated deficit | (260,226,000) | (205,578,000) | (165,751,000) | (135,936,000) | (93,586,000) | (60,434,000) | |||
| Total equity: | 21,518,000 | 20,899,000 | (1,448,000) | 8,303,000 | 28,042,000 | 37,286,000 | |||
| TOTAL LIABILITIES AND EQUITY: | 41,790,000 | 38,633,000 | 19,371,000 | 29,971,000 | 47,516,000 | 40,298,000 | |||
Income Statement (P&L) (USD)
| 3/31/2026 TTM | 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|---|---|---|
| Gross profit: | (54,552,000) | |||||||
| Operating expenses | (328,000) | (39,298,000) | (27,478,000) | (41,036,000) | (33,294,000) | (14,950,000) | ||
| Other undisclosed operating loss | ||||||||
| Operating loss: | (54,880,000) | (39,298,000) | (27,478,000) | (41,036,000) | (33,294,000) | (14,950,000) | ||
| Nonoperating income (expense) | 232,000 | (758,000) | (2,565,000) | (1,550,000) | (58,000) | 20,000 | ||
| Investment income, nonoperating | 1,495,000 | 2,356,000 | 825,000 | 199,000 | 17,000 | 69,000 | ||
| Other nonoperating income (expense) | (36,000) | (30,000) | (9,000) | 40,000 | (75,000) | (49,000) | ||
| Interest and debt expense | (819,000) | |||||||